Dedicated to preserving and improving life, directly, and through partnerships. 
The InnoVision Technology Awards program named Equi-Tox® , Inc. a first place winner in the Small Enterprises Technology Application category last night at an awards ceremony in Greenville, SC. The company was selected for its research on the Equine Fescue Toxicosis malady and the development of the drug domperidone [Equidone® (domperidone) Oral Gel]. The winning entry was chosen from among several, and was awarded to Equi-Tox® , Inc. for its outstanding technology as well as the implications it has for global change.
For more information about the InnoVision Awards, visit the website at http://www.innovisionaward.org.
Equi-Tox, Inc. is currently in the process of clearing Equidone (domperidone 11% w/v) with the FDA. For more information on Equidone please contact us.
Contributions for Research
Equi-Tox, Inc. makes annual allowances for other Universities and non-profit organizations that would like to conduct research on domperidone. For information and availability please contact us.
